Small intestine cancer incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of small intestine cancer, 2015-2017, UK

 

Proportion of all cases

Percentage small intestine cancer is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of small intestine cases, 2015-2017, UK

Trend over time

Change in small intestine cancer incidence rates since the early 1990s, UK

Small intestine cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).[1-4]

In females in the UK, small intestine cancer is not among the 20 most common cancers (less than 1% of all new female cancer cases). In males in the UK, it is not among the 20 most common cancers (less than 1% of all new male cancer cases).

45% of small intestine cancer cases in the UK are in females, and 55% are in males.

Small intestine cancer incidence rates (European age-standardised (AS) rates) are similar to the UK average in all the UK constituent countries.

Small Intestine Cancer (C17), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Cases 652 74 41 18 785
Crude Rate 2.3 2.7 2.6 1.9 2.3
AS Rate 2.4 2.6 2.4 2.1 2.4
AS Rate - 95% LCL 2.2 2.0 1.7 1.1 2.2
AS Rate - 95% UCL 2.5 3.2 3.2 3.0 2.5
Male Cases 821 89 33 31 974
Crude Rate 3.0 3.4 2.1 3.4 3.0
AS Rate 3.4 3.6 2.3 3.9 3.4
AS Rate - 95% LCL 3.2 2.9 1.5 2.5 3.2
AS Rate - 95% UCL 3.6 4.4 3.0 5.2 3.6
Persons Cases 1,473 163 74 49 1,759
Crude Rate 2.6 3.0 2.4 2.6 2.7
AS Rate 2.8 3.1 2.4 2.9 2.8
AS Rate - 95% LCL 2.7 2.6 1.8 2.1 2.7
AS Rate - 95% UCL 3.0 3.5 2.9 3.8 3.0

95% LCL and 95% UCL are the 95% lower and upper confidence limits  around the AS Rate

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C17.

Last reviewed:

Small intestine cancer incidence is strongly related to age, with the highest incidence rates being in older people. In the UK in 2015-2017, on average each year around a third of new cases (34%) were in people aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 30-34 and more steeply from around age 60-64 and drop in the oldest age groups.The highest rates are in in the 85 to 89 age group for females and the 80 to 84 age group for males.

Incidence rates are significantly lower in females than males in a number of (mainly older) age groups.The gap is widest at age 55 to 59, when the age-specific incidence rate is 1.6 times lower in females than males

Small intestine cancer (C17), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, UK, 2015-2017

For small intestine cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C17.1

Last reviewed:

Small intestine cancer European age-standardised (AS) incidence rates for females and males combined increased by 151% in the UK between 1993-1995 and 2015-2017.[1-4] The increase was of a similar size in females and males.

For females, small intestine cancer AS incidence rates in the UK increased by 151% between 1993-1995 and 2015-2017. For males, small intestine cancer AS incidence rates in the UK increased by 145% between 1993-1995 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), small intestine cancer AS incidence rates for females and males combined increased by 56%. In females AS incidence rates increased by 60%, and in males rates increased by 50%.

Small Intestine Cancer (ICD-10 C17), European Age-Standardised Incidence Rates, UK, 1993-2017

Small intestine cancer incidence rates have increased overall in all broad adult age groups in females and males combined in the UK since the early 1990s.[1-4] Rates in 25-49s have increased by 134%, in 50-59s have increased by 142%, in 60-69s have increased by 161%, in 70-79s have increased by 156%, and in 80+s have increased by 144%.

Small Intestine Cancer (ICD-10 C17), European Age-Standardised Incidence Rates, By Age, UK, 1993-2017

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C17.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.